John M. Abt
Net Worth
Last updated:
What is John M. Abt net worth?
The estimated net worth of Mr. John M. Abt is at least $4,452,670 as of 10 Feb 2022. He has earned $5,270 from insider trading and has received compensation worth at least $4,447,400 in Lannett Company, Inc..
What is the salary of John M. Abt?
Mr. John M. Abt salary is $444,740 per year as Vice President and Chief Quality & Operations Officer in Lannett Company, Inc..
How old is John M. Abt?
Mr. John M. Abt is 60 years old, born in 1965.
What stocks does John M. Abt currently own?
As insider, Mr. John M. Abt owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Lannett Company, Inc. (LCI) | Vice President and Chief Quality & Operations Officer | 128,815 | $0 | $0 |
What does Lannett Company, Inc. do?
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Group of companies, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was incorporated in 1942 and is headquartered in Trevose, Pennsylvania.
John M. Abt insider trading
Lannett Company, Inc.
Mr. John M. Abt has made only one insider trade between 2015-2022, according to the Form 4 filled with the SEC. He purchased 5,000 units of LCI stock worth $4,500 on 10 Feb 2022.
As of 10 Feb 2022 he still owns at least 128,815 units of LCI stock.
Lannett Company key executives
Lannett Company, Inc. executives and other stock owners filed with the SEC:
- Mr. John Kozlowski (53) Vice President of Fin., Chief Financial Officer & Principal Accounting Officer
- Mr. John M. Abt (60) Vice President and Chief Quality & Operations Officer
- Mr. Samuel H. Israel (63) Gen. Counsel & Chief Legal Officer
- Mr. Timothy C. Crew (64) Chief Executive Officer & Director
- Ms. Maureen M. Cavanaugh (66) Senior Vice President & Chief Commercial Operations Officer